Related Experiment Video
Updated: Jul 10, 2026

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues
Published on: February 19, 2019
Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous
Hui-min Neoh1, Longzhu Cui, Harumi Yuzawa
1Department of Bacteriology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, Japan 113-8421.
Abstract:
Multistep genetic alteration is required for methicillin-resistant Staphylococcus aureus (MRSA) to achieve the level of vancomycin resistance of vancomycin-intermediate S. aureus (VISA). In the progression of vancomycin resistance, strains with heterogeneous vancomycin resistance, designated hetero-VISA, are observed. In studying the whole-genome sequencing of the representative hetero-VISA strain Mu3 and comparing it with that of closely related MRSA strains Mu50 (VISA) and N315 (vancomycin-susceptible S. aureus [VSSA]), we identified a mutation in the response regulator of the graSR two-component regulatory system. Introduction of mutated graR, designated graR*, but not intact graR, designated graRn, could convert the hetero-VISA phenotype of Mu3 into a VISA phenotype which was comparable to that of Mu50. The same procedure did not appreciably increase the vancomycin resistance of VSSA strain N315, indicating that graR* expression was effective only in the physiological milieu of hetero-VISA cell to achieve a VISA phenotype. Interestingly, the overexpression of graR* increased the daptomycin MICs in both Mu3 and N315 and decreased the oxacillin MIC in N315.
Insights
A mutation in the graR gene drives the progression from heterogeneous vancomycin resistance (hetero-VISA) to vancomycin-intermediate Staphylococcus aureus (VISA). This graR* mutation specifically enhances vancomycin resistance in hetero-VISA strains.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) requires multistep genetic changes to develop vancomycin resistance.
- Heterogeneous vancomycin-intermediate S. aureus (hetero-VISA) represents an intermediate stage in this resistance progression.
Purpose of the Study:
- To identify genetic factors contributing to the development of vancomycin resistance in MRSA.
- To investigate the role of the graSR two-component system in vancomycin resistance.
Main Methods:
- Whole-genome sequencing of MRSA strains Mu3 (hetero-VISA), Mu50 (VISA), and N315 (vancomycin-susceptible S. aureus [VSSA]).
- Genetic manipulation to introduce mutated graR (graR*) and intact graR (graRn) into bacterial strains.
- Determination of minimum inhibitory concentrations (MICs) for vancomycin, daptomycin, and oxacillin.
Main Results:
- A mutation in the graR gene (response regulator of the graSR system) was identified in the hetero-VISA strain Mu3.
- Introduction of graR* converted the hetero-VISA phenotype of Mu3 to a VISA phenotype, while intact graRn did not.
- graR* expression enhanced vancomycin resistance in hetero-VISA but not VSSA, suggesting a specific physiological context is required.
- Overexpression of graR* increased daptomycin MICs and decreased oxacillin MICs in both Mu3 and N315 strains.
Conclusions:
- The graR* mutation is a key factor in the transition from hetero-VISA to VISA.
- The graSR system plays a critical role in modulating antibiotic resistance in Staphylococcus aureus.
- graR* influences resistance to multiple antibiotics, including vancomycin, daptomycin, and oxacillin.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Regulation of Bacterial Virulence
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Transformation
